Search

everythinglearnresearchcommunity

for

Search:↓

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Adrenal disorders can cause lasting brain and behavior issues in children.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.